Wall Street Analysts Believe BridgeBio Pharma (BBIO) Could Rally 63.87%: Here's is How to Trade

BridgeBio Pharma (BBIO) closed the last trading session at $35.68, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 58.47 indicates a 63.9% upside potential.The mean estimate comprises 17 short-term price targets with a standard deviation of $12.24. While the lowest estimate of$ 37 indicates a 3.7% increase from the current price level, the most optimistic analyst expe ...